PeterSpornMDFCCP, ATSF
Pulmonology • Chicago, ILCritical Care Medicine, Interstitial Lung Diseases
Professor of Medicine, Cell and Developmental Biology, and Medical Education, Feinberg School of Medicine, Northwestern University
Dr. Sporn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Northwestern University Feinberg School of Medicine
303 E. Superior St., SQBRC 5-302
Chicago, IL 60611Phone+1 312-908-8163Fax+1 312-503-0411- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1983 - 1984
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1980 - 1983
Wayne State University School of MedicineClass of 1980
Certifications & Licensure
IL State Medical License 1991 - 2026
MI State Medical License 1985 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Member, Pulmonary Disease Board American Board of Internal Medicine
- Regional Top Doctor Castle Connolly, 2005-2021
- Chair, Pulmonary Disease Exam Writing Committee American Board of Internal Medicine
- Join now to see all
Clinical Trials
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension Start of enrollment: 2008 Nov 01
- Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis Start of enrollment: 2019 Jan 29
- Routine Cardiac Screening in Sarcoidosis Patients Start of enrollment: 2019 Apr 05
- Join now to see all
Publications & Presentations
PubMed
- Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.Casalino-Matsuda, S., Chen, F., Gonzalez-Gonzalez, F., Matsuda, H., Nair, A., Abdala-Valencia, H., Budinger, G., Dong, J., Beitel, G., Sporn, P.> ;JCI Insight. 2024 Jan 16
- Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol.Fei Chen, Aiko Matsuda, G R Scott Budinger, Peter H S Sporn, S Marina Casalino-Matsuda> ;Frontiers in Immunology. 2023 Jan 1
- 8 citationsEfzofitimod for the Treatment of Pulmonary Sarcoidosis.Daniel A Culver, Joseph Barney, Connie C W Hsia, W Ennis James, Lisa A Maier, Lucian T Marts, Ogugua Ndili Obi, Peter H S Sporn, Nadera J Sweiss, Sanjay Shukla, Nelson...> ;Chest. 2023 Apr 1
- Join now to see all
Grant Support
- Clinical Studies NetworkFoundation for Sarcoidosis Research2018–2022
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2017–2020
- Hypercapnia and Suppression of Antiviral Host DefenseNational Institutes of Health2016–2017
Committees
- Program Committee, Asthma, Allergy and Inflammation Assembly 2021 - Present
- Member, ABIM Pulmonary Disease Board 2020 - Present
- Chair, ABIM Pulmonary Disease Board Examination Writing Committee 2018 - Present
- Member, American Thoracic Society Scientific Advisory Committee 2018 - Present
- Member, Veterans Affairs Pulmonary Grant Review Panel 2018 - Present
- Member, ABIM Pulmonary Disease Board Examination Writing Committee 2010 - 2018
Professional Memberships
- Member
- World Association of Sarcoidosis and Other Granulomatous DisordersMember
- Americas Association of Sarcoidosis and Other DisordersMember
- Fellow
- Fellow
Other Languages
- Spanish
Hospital Affiliations
Jesse Brown VA Medical CenterChicago, Illinois
Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
